Utility of hematological and inflammatory biomarkers in predicting recovery in critical Covid-19 patients: Our experience in the largest Covid-19 treating center in Lebanon.

Hassan Salame Rashad NawfalJad KassemRemy MckeyAli KassemNayef AlKhalilMohamad SalehAli Hussein Abdel SaterAli IbrahimLinda Abou-AbbasOussaima EldbouniHoda KhatounBassam Matar

Published in: PloS one (2022)

Our results confirm that inexpensive tests like lymphocyte count and CRP can be reliably used to follow COVID-19 patients in ICU and to support the decision to discharge patients.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
intensive care unit
peripheral blood
peritoneal dialysis
patient reported outcomes
extracorporeal membrane oxygenation